GEHC

NASDAQ · Health Care

Ge Healthcare Technology

S&P 500 Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Healthcare Stocks Best Dividend Stocks

$63.47

+2.13 (+3.47%)

As of May 8, 9:35 PM ET ·

Financial Highlights (FY 2026)

Revenue

20.42B

Net Income

2.06B

Gross Margin

40.0%

Profit Margin

10.1%

Rev Growth

+4.0%

D/E Ratio

0.97

Revenue & Net Income

Margin Trends

	FY 2026	FY 2025	FY 2024	FY 2023
Gross Margin	40.0%	40.0%	42.3%	42.3%
Operating Margin	13.4%	12.1%	13.2%	14.7%
Profit Margin	10.1%	9.6%	10.0%	10.8%

Income Statement

	FY 2026	FY 2025	FY 2024	FY 2023
Revenue	20.42B	19.64B	15.42B	13.77B
Gross Profit	8.17B	7.85B	6.51B	5.82B
Operating Income	2.74B	2.37B	2.03B	2.03B
Net Income	2.06B	1.79B	1.54B	1.48B
Gross Margin	40.0%	40.0%	42.3%	42.3%
Operating Margin	13.4%	12.1%	13.2%	14.7%
Profit Margin	10.1%	9.6%	10.0%	10.8%
Rev Growth	+4.0%	+4.0%	-4.4%	+20.7%

Balance Sheet

	FY 2026	FY 2025	FY 2024	FY 2023
Total Debt	6.81B	6.81B	3.20B	2.89B
Total Equity	7.03B	7.03B	21.16B	22.20B
D/E Ratio	0.97	0.97	0.15	0.13

Cash Flow

	FY 2026	FY 2025	FY 2024	FY 2023
EBITDA	3.32B	3.03B	2.74B	2.82B
Free Cash Flow	—	—	1.88B	1.51B